Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Raaj Medisafe India Ltd.
Source DateBoard Meeting DateDetails
23-May-2025 29-May-2025 Audited Results
20-May-2025 27-May-2025 Audited Results(Cancelled) (Cancelled)
24-Mar-2025 29-Mar-2025 Inter-alia, to consider and approve sale of Building and shed situated at Plot No. 75/4, Industrial Area, Maksi Road, Ujjain-456010.
03-Feb-2025 11-Feb-2025 Quarterly Results
05-Nov-2024 12-Nov-2024 Quarterly Results
12-Aug-2024 14-Aug-2024 Quarterly Results
22-May-2024 29-May-2024 Audited Results
03-May-2024 06-May-2024 Preferential Issue of shares
23-Feb-2024 29-Feb-2024 Increase in Authorised Capital & Preferential Issue of shares
31-Jan-2024 09-Feb-2024 Quarterly Results
08-Jan-2024 16-Jan-2024 To consider and approve expansion of existing manufacturing capacities of the Company as per letter attached.
30-Oct-2023 08-Nov-2023 Quarterly Results
31-Jul-2023 08-Aug-2023 Quarterly Results & A.G.M.
23-May-2023 29-May-2023 Audited Results
06-Feb-2023 13-Feb-2023 Quarterly Results (Revised)
31-Jan-2023 08-Feb-2023 Quarterly Results
31-Oct-2022 11-Nov-2022 Quarterly Results
01-Aug-2022 09-Aug-2022 Quarterly Results
18-May-2022 25-May-2022 Audited Results
07-Feb-2022 14-Feb-2022 Quarterly Results
Page 1 of 4
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.